SELLAS Life Sciences (SLS) Return on Capital Employed Growth (5y) (2017 - 2026)
SELLAS Life Sciences (SLS) Return on Capital Employed Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | SELLAS Life Sciences | 3.23 Mn | 3.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 557.00 |
| Dec 31, 2025 | 3,635.00 |
| Sep 30, 2025 | 9,928.00 |
| Jun 30, 2025 | 8,835.00 |
| Mar 31, 2025 | 2,945.00 |
| Dec 31, 2022 | -39,162.00 |
| Sep 30, 2022 | -24,543.00 |
| Jun 30, 2022 | -27,531.00 |
| Mar 31, 2022 | 27,270.00 |
| Dec 31, 2021 | -4,603.00 |
| Sep 30, 2021 | 5,475.00 |
| Jun 30, 2021 | 11,039.00 |
| Mar 31, 2021 | 6,639.00 |
| Dec 31, 2020 | 4,991.00 |
| Sep 30, 2020 | -10,833.00 |
| Jun 30, 2020 | -12,978.00 |
| Mar 31, 2020 | -9,280.00 |
| Dec 31, 2017 | -2,747.00 |